Cargando…
Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups
This multicenter prospective phase 2 trial analyzed disease-free survival (DFS) in myelofibrosis patients receiving ruxolitinib for 6 months before transplantation. Seventy-six patients were recruited. Age-adjusted dynamic international prognostic scoring system was intermediate-1, intermediate-2, a...
Autores principales: | Robin, Marie, Porcher, Raphael, Orvain, Corentin, Bay, Jacques-Olivier, Barraco, Fiorenza, Huynh, Anne, Charbonnier, Amandine, Forcade, Edouard, Chantepie, Sylvain, Bulabois, Claude, Yakoub-Agha, Ibrahim, Detrait, Marie, Michonneau, David, Turlure, Pascal, Raus, Nicole, Boyer, Françoise, Suarez, Felipe, Vincent, Laure, Guyen, Stéphanie N., Cornillon, Jérôme, Villate, Alban, Dupriez, Brigitte, Cassinat, Bruno, Rolland, Valérie, Schlageter, Marie Hélène, Socié, Gérard, Kiladjian, Jean-Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992510/ https://www.ncbi.nlm.nih.gov/pubmed/33767402 http://dx.doi.org/10.1038/s41409-021-01252-7 |
Ejemplares similares
-
Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)
por: Pochon, Cécile, et al.
Publicado: (2021) -
Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study
por: Xhaard, Alienor, et al.
Publicado: (2020) -
Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
por: Robin, Marie, et al.
Publicado: (2022) -
Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC
por: Jondreville, Ludovic, et al.
Publicado: (2022) -
Comment faire face à un événement inattendu pouvant modifier l’activité normale de thérapie cellulaire ? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
por: Bay, Jacques Olivier, et al.
Publicado: (2021)